InsidersTradesSigma
Follow the 国药现代 share price and the full insider trade history of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 国药现代 has logged 3 insider filings. Market capitalisation: €11.7bn. The latest transaction was filed on 12 April 2023 (Purchase). Among the most active insiders: 李显林. The full history is accessible without an account.
3
Insider Decl.
n/a
Thresholds
€36,249
3 ops.
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,630 of 29,064 companies
74.8
score / 100
Value85
Quality65
FCF yld12%
Earn yld8.1%
EV/EBITDA5.7x
ROE5.7%
Gross mgn32%
Net mgn10%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 April 2023
关于 国药现代
国药现代是一家在医疗保健和制药领域运营的公司，在上海证券交易所上市。它专注于药品的研发和分销。